Modelling the global impact of the 13-valent pneumococcal vaccine on antibiotic use for otitis media

被引：0
|
作者：
Moffatt, M. [1 ]
Wasserman, M. [1 ]
机构：
[1] Pfizer Inc, Hlth Econ & Outcomes Res, New York, NY USA
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2020年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：V1062 / V1062
页数：1
相关论文
共 50 条
  • [21] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
  • [22] National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States
    Zhou, Xiaofeng
    de Luise, Cynthia
    Gaffney, Michael
    Burt, Catharine W.
    Scott, Daniel A.
    Gatto, Nicolle
    Center, Kimberly J.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 119 : 96 - 102
  • [23] Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
    Esposito, Susanna
    Principi, Nicola
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [24] Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
    Bryant, Kristina A.
    Block, Stan L.
    Baker, Sherryl A.
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRICS, 2010, 125 (05) : 866 - 875
  • [25] Hypotonic hyporesponsive episode and the 13-valent pneumococcal vaccine
    Fotis, Lampros
    Vazeou, Andriani
    Xatzipsalti, Maria
    Stamoyannou, Lela
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (04) : 427 - 429
  • [26] Pneumococcal Carriage and Antibiotic Resistance in Young Children Before 13-valent Conjugate Vaccine
    Wroe, Peter C.
    Lee, Grace M.
    Finkelstein, Jonathan A.
    Pelton, Stephen I.
    Hanage, William P.
    Lipsitch, Marc
    Stevenson, Abbie E.
    Rifas-Shiman, Sheryl L.
    Kleinman, Ken
    Dutta-Linn, M. Maya
    Hinrichsen, Virginia L.
    Lakoma, Matthew
    Huang, Susan S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (03) : 249 - 254
  • [27] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +
  • [28] Assessing the baseline burden of otitis media in children 2 to 3 years of age for estimating the effecfs of 13-valent pneumococcal conjugate vaccine (PCV) on otitis media
    Libwea, J. Njuma
    Kobela, M.
    Ndombo, P. Koki
    Syrjanen, R.
    Huhtala, H.
    Fointama, N.
    Shiro, K.
    Nohynek, H.
    Nourti, P.
    Palmu, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 234 - 235
  • [29] Invasive Pneumococcal Disease and the Need for the New 13-valent Pneumococcal Vaccine
    Bolton, Michael
    Barson, William
    PEDIATRIC ANNALS, 2010, 39 (08): : 497 - 503
  • [30] Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
    Rodrigo, Chamira
    Bewick, Thomas
    Sheppard, Carmen
    Greenwood, Sonia
    Mckeever, Tricia M.
    Trotter, Caroline L.
    Slack, Mary
    George, Robert
    Lim, Wei Shen
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1632 - 1641
12345